Owlstone introduces ReCIVA breath samplerNovember 15, 2019
Owlstone Medical has launched a new ReCIVA breath sampler and CASPER portable air supply, designed to support internal biomarker discovery programmes and those of academic and biopharma clients, and to measure levels of known volatile organic compounds (VOCs) on the breath.
The company has implemented new software to monitor subject breathing and VOC collection through ReCIVA, including a simpler user interface and the ability to set different levels of access to settings for different users.
Breath Biopsy represents an entirely new way to measure the chemical makeup of breath by measuring VOCs, which are gaseous molecules that can be sampled quickly and non-invasively from breath and enabling whole-body sampling.
Breath collection is carried out using Owlstone Medical’s ReCIVA breath sampler. Subjects breathe a controlled supply of air, and samples of their exhaled breath are captured and stabilized on Breath Biopsy cartridges, which can then be shipped for analysis using mass spectrometry or FAIMS to determine their VOC profile. Advanced data analytic techniques can then be applied in order to pinpoint the VOCs of interest.